Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The typical workflow for AI-powered biomaterial design, as illustrated in Fig
Matthias LJ, Yam PT, Jiang XM, Vandegraaff N, Li P, Poumbourios P, et al
Both Novo Nordisk and Eli Lilly, alongside other Big Pharma players, have pursued or are pursuing additional trials and research exploring additional diseases and conditions where GLP-1 drugs and their successors may be effective treatments
Five distinct mechanisms drive injection site reactions with GLP-1 receptor agonists, and most reactions involve more than one mechanism operating simultaneously
Rather than functioning as a single-target receptor agonist, GLP-RTprovides a model system for investigating tri-agonist biology and receptor crosstalk
Financials 15.3.9.4
US$ 24.21
US$ 21.23
US$ 21.89
US$ 21.51
US$ 24.80
